Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | 6 | 19 | 20 | 8 | 52 |
Ankylosing spondylitis | D013167 | EFO_0003898 | M45 | 1 | 2 | 1 | 7 | 3 | 13 |
Psoriatic arthritis | D015535 | EFO_0003778 | L40.5 | — | — | 1 | 2 | 2 | 5 |
Juvenile arthritis | D001171 | EFO_1002007 | M08 | — | — | 1 | 1 | — | 2 |
Spondylarthritis | D025241 | — | — | — | — | — | 1 | — | 1 |
Heart disease risk factors | D000082742 | — | — | — | — | — | 1 | — | 1 |
Vascular stiffness | D059289 | — | — | — | — | — | 1 | — | 1 |
Therapeutics | D013812 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ulcerative colitis | D003093 | EFO_0000729 | K51 | — | — | 1 | — | 2 | 3 |
Spondylarthropathies | D025242 | EFO_0000706 | M47 | — | — | 1 | — | — | 1 |
Neoplasms | D009369 | — | C80 | — | — | 1 | — | — | 1 |
Diarrhea | D003967 | HP_0002014 | R19.7 | — | — | 1 | — | — | 1 |
Oral lichen planus | D017676 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Glioblastoma | D005909 | EFO_0000515 | — | 2 | 1 | — | — | — | 2 |
Pulmonary arterial hypertension | D000081029 | — | — | 1 | 1 | — | — | — | 1 |
Peripheral arterial disease | D058729 | EFO_0004265 | — | — | 1 | — | — | — | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | — | — | — | 1 |
Chronic pain | D059350 | HP_0012532 | — | — | 1 | — | — | — | 1 |
Sclerosing cholangitis | D015209 | EFO_0004268 | K83.01 | — | 1 | — | — | — | 1 |
Premature birth | D047928 | EFO_0003917 | O60 | — | 1 | — | — | — | 1 |
Myeloid leukemia acute | D015470 | — | C92.0 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 3 | — | — | — | — | 3 |
Intestinal obstruction | D007415 | — | K56.60 | 2 | — | — | — | — | 2 |
Magnetic resonance imaging | D008279 | — | — | 1 | — | — | — | — | 1 |
Oral administration | D000284 | — | — | 1 | — | — | — | — | 1 |
Pharmacokinetics | D010599 | — | — | 1 | — | — | — | — | 1 |
Osteomyelitis | D010019 | EFO_0003102 | M86 | 1 | — | — | — | — | 1 |
Vomiting | D014839 | HP_0002013 | R11.1 | 1 | — | — | — | — | 1 |
Drug interactions | D004347 | — | — | 1 | — | — | — | — | 1 |
Glioma | D005910 | EFO_0000520 | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Psoriasis | D011565 | EFO_0000676 | L40 | — | — | — | — | 2 | 2 |
Systemic scleroderma | D012595 | EFO_0000717 | M34 | — | — | — | — | 1 | 1 |
Inflammatory bowel diseases | D015212 | EFO_0003767 | — | — | — | — | — | 1 | 1 |
Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 1 | 1 |
Recurrence | D012008 | — | — | — | — | — | — | 1 | 1 |
Esophageal neoplasms | D004938 | — | C15 | — | — | — | — | 1 | 1 |
Nutrition disorders | D009748 | EFO_0001069 | — | — | — | — | — | 1 | 1 |
Dumping syndrome | D004377 | EFO_1001307 | K91.1 | — | — | — | — | 1 | 1 |
Feeding and eating disorders | D001068 | — | F50 | — | — | — | — | 1 | 1 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | — | — | — | — | 1 | 1 |
Drug common name | Sulfasalazine |
INN | sulfasalazine |
Description | Sulfasalazine is an azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position. It has a role as a non-steroidal anti-inflammatory drug, an antiinfective agent, a gastrointestinal drug, an EC 2.5.1.18 (glutathione transferase) inhibitor, a drug allergen and a ferroptosis inducer. It is a sulfonamide, a member of pyridines and a member of azobenzenes. It is functionally related to a sulfanilamide. |
Classification | Small molecule |
Drug class | antiarrhythmic/antianginal/antihypertensive agents, phthalazine like structure; anti-inflammatory agents (salicylic acid derivatives); antimicrobials (sulfonamides derivatives) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O |
PDB | — |
CAS-ID | 599-79-1 |
RxCUI | — |
ChEMBL ID | CHEMBL421 |
ChEBI ID | 9334 |
PubChem CID | 5339 |
DrugBank | DB00795 |
UNII ID | 3XC8GUZ6CB (ChemIDplus, GSRS) |